Cardiogrit Gold: A Solution for Heart Diseases Caused by Cancer Medications!
A recent study conducted by Patanjali has confirmed that Cardiogrit Gold, a herbo-mineral formulation developed by Patanjali scientists, can effectively counteract the cardiotoxicity caused by Doxorubicin, a widely used chemotherapy drug.

Swami Ramdev and Acharya Balkrishna |
Haridwar: Patanjali has once again demonstrated that even the most serious diseases can be treated through Ayurveda when combined with modern science. A recent study conducted by Patanjali has confirmed that Cardiogrit Gold, a herbo-mineral formulation developed by Patanjali scientists, can effectively counteract the cardiotoxicity caused by Doxorubicin, a widely used chemotherapy drug.
On this occasion, Acharya Balkrishna stated that this research not only establishes the scientific relevance of Ayurveda on the global stage but also proves that if traditional medical systems are tested through a scientific lens, they can offer solutions to even the most complex challenges in modern medicine.
Cardiogrit Gold is made using classical Ayurvedic ingredients such as Yogendra Ras, Arjuna, Moti Pishti, Akik Pishti, and other herbs and mineral-based preparations traditionally recognized for their efficacy in heart-related ailments.
Acharya Balkrishna further said that this study is not only a result of the tireless efforts of Patanjali’s scientists, but it also symbolizes the revival of India’s eternal medical science – Ayurveda. At a time when the entire world is eager to embrace the ancient Ayurvedic tradition, this research reinforces that faith and gives people a compelling reason to adopt Ayurveda.
This study is a significant step toward the renaissance of Ayurveda, and it demonstrates that the integration of tradition and science is a priceless gift to humanity.
The study, conducted using the C. elegans model, confirmed that Cardiogrit Gold improved food intake in the organisms, enhanced the condition of heart-like muscles, reduced ROS (Reactive Oxygen Species) levels, and significantly improved body length and reproductive capacity. The medicine also reduced Doxorubicin levels in these organisms, validating its effectiveness in mitigating cardiotoxicity.
This research has been published in the prestigious international journal, the Journal of Toxicology, by Wiley Publications.
ALSO READ
To learn more about our research and how this formulation affects the organisms studied, you can click on the following link: https://onlinelibrary.wiley.com/doi/10.1155/jt/4609428
https://onlinelibrary.wiley.com/doi/10.1155/jt/4609428
RECENT STORIES
-
Al-Ahli Vs Al-Wasl Clash: Fans Throw Water Bottles At Injured Saleh Abu Al-Shamat As He Leaves On... -
Mumbai Police Tighten Security For Navratri 2026; CCTV, Plain-Clothes Patrolling At Garba Venues,... -
'I Have Not Been Transferred': Tukaram Mundhe Clarifies Role As FDA Commissioner Amid MPSC Probe... -
Ulhasnagar: Traffic Police Recover Scooter Stolen In 2024 After E-Challan System Reveals Chassis... -
Indian Navy Strengthens Anti-Submarine Preparedness With Commissioning Of INS Mangrol At Mumbai
